MARKET

OABI

OABI

OmniAb, Inc.
NASDAQ
4.360
-0.100
-2.24%
After Hours: 4.350 -0.01 -0.23% 16:19 01/27 EST
OPEN
4.460
PREV CLOSE
4.460
HIGH
4.600
LOW
4.300
VOLUME
353.40K
TURNOVER
0
52 WEEK HIGH
10.50
52 WEEK LOW
1.910
MARKET CAP
429.58M
P/E (TTM)
-13.9075
1D
5D
1M
3M
1Y
5Y
BRIEF-Omniab Inc Preliminary Unaudited Cash Cash Equivalents And Marketable Securities As Of Dec 31 2022 About $88 Mln
Reuters · 01/09 22:06
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
Benzinga · 12/20/2022 15:01
--Truist Starts OmniAb at Buy With $10 Price Target
--Truist Starts OmniAb at Buy With $10 Price Target
MT Newswires · 12/20/2022 09:02
Some 'Transgenic Animal Platforms Are More Than Equal,' Analyst Initiating Coverage On OmniAb Says
Benzinga · 12/16/2022 17:39
Credit Suisse Initiates Coverage On OmniAb with Outperform Rating, Announces Price Target of $13
Benzinga · 12/16/2022 13:30
--Credit Suisse Initiates OmniAb at Outperform Rating With $13 Price Target
--Credit Suisse Initiates OmniAb at Outperform Rating With $13 Price Target
MT Newswires · 12/16/2022 09:25
Insider Buy: Omniab
Insider Buy: Omniab
MT Newswires · 12/14/2022 17:10
$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying
Benzinga · 12/02/2022 13:43
More
About OABI
OmniAb, Inc. operates as a discovery platform that provides pharmaceutical industry partners with access to diverse antibody repertoires and high-throughput screening technologies to enable the discovery of next-generation therapeutics. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. Its OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach and OmniTaur features structural attributes of cow antibodies for complex targets. The Company's OmniChicken and OmniClic offer affinity-matured antibodies in an evolutionarily distant chicken host environment, which can deliver a diverse repertoire of antibody panels to conserved therapeutic targets.

Webull offers kinds of OmniAB Inc stock information, including NASDAQ:OABI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OABI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OABI stock methods without spending real money on the virtual paper trading platform.